Currently holds a position at Accelerate Diagnostics Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer | Accelerate Diagnostics Inc | Sept. 10, 2012 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-03-13 | 2023-03-08 |
Accelerate Diagnostics Inc
(AXDX)
|
S Sale |
62,778
-31.3%
0.4729,506 USD |
62,778 -31.3% | 0.47 | 29,506 USD | |
2023-02-15 | 2023-02-13 |
Accelerate Diagnostics Inc
(AXDX)
|
S Sale |
4,823
-5.9%
0.602,894 USD |
4,823 -5.9% | 0.60 | 2,894 USD | |
2022-08-22 | 2022-08-22 |
Accelerate Diagnostics Inc
(AXDX)
|
B Purchase |
5,000
+8.0%
1.396,950 USD |
5,000 +8.0% | 1.39 | 6,950 USD | |
2022-04-28 | 2022-04-28 |
Accelerate Diagnostics Inc
(AXDX)
|
S Sale |
29,915
-32.4%
0.9829,317 USD |
29,915 -32.4% | 0.98 | 29,317 USD | |
2021-01-27 | 2021-01-27 |
Accelerate Diagnostics Inc
(AXDX)
|
S Sale |
25,000
-65.3%
15.25381,250 USD |
25,000 -65.3% | 15.25 | 381,250 USD | |
2021-01-27 | 2021-01-26 |
Accelerate Diagnostics Inc
(AXDX)
|
S Sale |
24,910
-65.2%
12.50311,375 USD |
24,910 -65.2% | 12.50 | 311,375 USD | |
2021-01-27 | 2021-01-25 |
Accelerate Diagnostics Inc
(AXDX)
|
S Sale |
20,761
-61.0%
10.55219,029 USD |
20,761 -61.0% | 10.55 | 219,029 USD | |
2021-02-03 | 2020-12-17 |
Accelerate Diagnostics Inc
(AXDX)
|
S Sale |
859
-5.2%
7.376,331 USD |
859 -5.2% | 7.37 | 6,331 USD | |
2020-11-12 | 2020-11-09 |
Accelerate Diagnostics Inc
(AXDX)
|
S Sale |
39,329
-74.7%
9.50373,626 USD |
39,329 -74.7% | 9.50 | 373,626 USD | |
2020-03-19 | 2020-03-19 |
Accelerate Diagnostics Inc
(AXDX)
|
B Purchase |
1,000
+8.1%
6.926,920 USD |
1,000 +8.1% | 6.92 | 6,920 USD |